Optimal duration of anticoagulation in patients with venous thromboembolism. The risk of recurrent venous thromboembolism (VTE) approaches 40 per cent of all patients after 10 yr of follow up. This risk is higher in patients with permanent risk factors of thrombosis such as active cancer, prolonged immobilization from medical diseases, and antiphospholipid syndrome in carriers of several thrombophilic abnormalities, including deficiencies of natural anticoagulants